Senzime AB (SEZI) - Total Liabilities
Based on the latest financial reports, Senzime AB (SEZI) has total liabilities worth Skr66.51 Million SEK (≈ $7.16 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Senzime AB to track the company's year-over-year net asset growth rate.
Senzime AB - Total Liabilities Trend (2005–2025)
This chart illustrates how Senzime AB's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Senzime AB to measure how efficiently the company converts operating cash flow to free cash.
Senzime AB Competitors by Total Liabilities
The table below lists competitors of Senzime AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cryomax Cooling System Corp
TW:1587
|
Taiwan | NT$2.13 Billion |
|
3P Learning Ltd
AU:3PL
|
Australia | AU$58.50 Million |
|
Kredyt Inkaso SA
WAR:KRI
|
Poland | zł564.43 Million |
|
Korea Computer & Systems Inc
KQ:115500
|
Korea | ₩7.26 Billion |
|
Kronox Lab Sciences Ltd
NSE:KRONOX
|
India | Rs113.96 Million |
|
Nurminen Logistics Oyj
HE:NLG1V
|
Finland | €57.24 Million |
Liability Composition Analysis (2005–2025)
This chart breaks down Senzime AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Senzime AB (SEZI) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.76 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Senzime AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Senzime AB (2005–2025)
The table below shows the annual total liabilities of Senzime AB from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr65.35 Million ≈ $7.03 Million |
-16.94% |
| 2024-12-31 | Skr78.67 Million ≈ $8.47 Million |
+35.49% |
| 2023-12-31 | Skr58.06 Million ≈ $6.25 Million |
-4.46% |
| 2022-12-31 | Skr60.78 Million ≈ $6.54 Million |
+152.80% |
| 2021-12-31 | Skr24.04 Million ≈ $2.59 Million |
-12.72% |
| 2020-12-31 | Skr27.55 Million ≈ $2.96 Million |
+14.45% |
| 2019-12-31 | Skr24.07 Million ≈ $2.59 Million |
-19.10% |
| 2018-12-31 | Skr29.75 Million ≈ $3.20 Million |
+16.33% |
| 2017-12-31 | Skr25.57 Million ≈ $2.75 Million |
+4.63% |
| 2016-12-31 | Skr24.44 Million ≈ $2.63 Million |
+1126.44% |
| 2015-12-31 | Skr1.99 Million ≈ $214.46K |
-10.94% |
| 2014-12-31 | Skr2.24 Million ≈ $240.79K |
+91.47% |
| 2013-12-31 | Skr1.17 Million ≈ $125.76K |
-6.29% |
| 2012-12-31 | Skr1.25 Million ≈ $134.19K |
-67.12% |
| 2011-12-31 | Skr3.79 Million ≈ $408.17K |
-5.82% |
| 2010-12-31 | Skr4.03 Million ≈ $433.39K |
-11.76% |
| 2009-12-31 | Skr4.56 Million ≈ $491.13K |
-5.42% |
| 2008-12-31 | Skr4.83 Million ≈ $519.27K |
+11.44% |
| 2007-12-31 | Skr4.33 Million ≈ $465.98K |
+34.39% |
| 2006-12-31 | Skr3.22 Million ≈ $346.74K |
+7.22% |
| 2005-12-31 | Skr3.00 Million ≈ $323.39K |
-- |
About Senzime AB
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, quantitative train of-four (TOF) monitoring refined by real-world patient data; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impeda… Read more